The market for pharmaceutical manufacturing equipment is expanding quickly due to the increasing demand for pharmaceuticals, particularly generic medications. Generic medications provide a cost-effective substitute for brand-name drugs and have...
The expansion of Indian CDMOs and CROs will accelerate because of the generally positive environment. As per Mordor Intelligence, the contract manufacturing sector is expected to double within the next five years, reaching $44.63 billion...
The medical devices market ranks as the fourth largest in Asia, following Japan, China, and South Korea, and is among the top twenty medical devices markets globally, expanding at a compound annual growth rate (CAGR) of 15 percent. The production...
The Union government has sanctioned a financial allocation of Rs 15,000 crore for the Production Linked Incentive (PLI) scheme in pharmaceuticals, intended to enhance domestic production. In a written response to Lok Sabha, Union Minister of State...
The expanding pipeline of small molecule medications, their rising intricacy, and the requirement for specialized knowledge are fueling the demand for pharmaceutical contract manufacturing in the fill-finish sector. Moreover, with a greater focus...
The global increase in investment, consequently fueling a significant recovery in developed markets, is observed as a vital market driver for the pharmaceutical-grade synthetic camphor market. Nonetheless, the change in positive market sentiments...
The increasing preference for biologics and biosimilars is fueling the demand for the sterile injectable contract manufacturing sector. The market size for sterile injectable contract manufacturing was worth USD 15.96 billion in 2024 and is...
India has played a significant role in supplying cost-effective generic drugs, supporting healthcare systems worldwide for a considerable amount of time. Yet, worries have arisen about the provision of healthcare in countries relying on these...
India's status as the "pharmacy of the world" is based on its ability to create drug details and nonexclusive medications. Be that as it may, this standing lays on a tricky establishment, with roughly 70% of its Dynamic Drug Fixings (APIs) obtained..
Long-term health management products, specifically chronic therapies, have been driving the growth of the Indian Pharmaceutical Market (IPM) with a 10% increase, in contrast to acute therapies which saw a 2% growth, showing a trend towards prolong...
, CDSCO.jpg)
.jpg)